We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
+10.24%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$350M
AUM Growth
+$27.1M
Cap. Flow
+$3.41M
Cap. Flow %
0.98%
Top 10 Hldgs %
59.99%
Holding
41
New
2
Increased
2
Reduced
5
Closed
–

Top Buys

Rank Stock Value
1
BBNX
Beta Bionics
BBNX
+$8.15M
2
APOG icon
Apogee Enterprises
APOG
+$1.85M
3
SUPN icon
Supernus Pharmaceuticals
SUPN
+$911K
4
FATE icon
Fate Therapeutics
FATE
+$73K

Top Sells

Rank Stock Value
1
VICR icon
Vicor
VICR
+$4.13M
2
DUK icon
Duke Energy
DUK
+$1.25M
3
NEE icon
NextEra Energy
NEE
+$889K
4
XEL icon
Xcel Energy
XEL
+$784K
5
KOD icon
Kodiak Sciences
KOD
+$517K

Sector Composition

Rank Sector Weight
1 Healthcare 26.91%
2 Utilities 23.53%
3 Industrials 17.79%
4 Financials 8%
5 Consumer Staples 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UHAL icon
26
U-Haul Holding Co
UHAL
$13.9B
$3.53M 1.01%
73,900
– –
RLI icon
27
RLI Corp
RLI
$5.66B
$2.33M 0.67%
40,800
– –
LLY icon
28
Eli Lilly
LLY
$1.05T
$1.84M 0.53%
2,000
– –
APOG icon
29
Apogee Enterprises
APOG
$856M
$1.68M 0.48%
+50,000
New +$1.85M
FOCL
30
EDAP TMS S.A.
FOCL
$204M
$1.63M 0.47%
438,652
– –
VG
31
Venture Global Inc
VG
$34.3B
$1.58M 0.45%
100,000
– –
PSNL icon
32
Personalis
PSNL
$1.61B
$1.48M 0.42%
233,000
– –
SIRI icon
33
SiriusXM
SIRI
$10.3B
$1.29M 0.37%
55,784
– –
FATE icon
34
Fate Therapeutics
FATE
$324M
$947K 0.27%
789,188
+60,000
+8% +$73K
ASH icon
35
Ashland
ASH
$3.14B
$834K 0.24%
15,000
– –
VTRS icon
36
Viatris
VTRS
$20.1B
$787K 0.23%
58,279
– –
BHC icon
37
Bausch Health
BHC
$1.8B
$670K 0.19%
124,000
– –
MNKD icon
38
MannKind Corp
MNKD
$1.25B
$478K 0.14%
195,073
– –
CRBU icon
39
Caribou Biosciences
CRBU
$164M
$475K 0.14%
250,000
– –
WEC icon
40
WEC Energy
WEC
$36.9B
$457K 0.13%
3,945
– –
MASS icon
41
908 Devices
MASS
$302M
$418K 0.12%
68,286
– –
1
2

Similar funds

RFS
Retirement Financial Solutions Knoxville, Tennessee $350M AUM 16.94% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $350M AUM 39.2% 1-Year Est. Return
PCM
Pennsylvania Capital Management Huntingdon Valley, Pennsylvania $349M AUM 20.19% 1-Year Est. Return
SA
SRH Advisors Salina, Kansas $349M AUM 10.46% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
LAS
Lloyd Advisory Services Suwanee, Georgia $349M AUM 13.97% 1-Year Est. Return
GAA
Global Assets Advisory Orlando, Florida $349M AUM 24.2% 1-Year Est. Return

Bruce & Co's Q1 2026 Portfolio in Review

As of Q1 2026, Bruce & Co held 41 positions worth $350M, up 8.4% from $323M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 4.9%. Bruce & Co opened 2 new positions and made no exits, leaving the 41-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Utilities and Industrials.

  • Bruce & Co's largest Q1 2026 buy was Beta Bionics: 550,700 shares worth $5.52M.
  • Bruce & Co added most to Supernus Pharmaceuticals in Q1 2026, an estimated $911K increase.
  • Bruce & Co's biggest Q1 2026 reduction was Vicor, cutting an estimated $4.13M.
  • Bruce & Co's ten largest holdings make up 60% of its $350M portfolio in Q1 2026.
  • Bruce & Co opened 2 new positions and closed 0 in Q1 2026.
  • Bruce & Co's portfolio value rose 8.4% quarter-over-quarter to $350M.

Based on Bruce & Co's 13F filing for Q1 2026, filed 14 May 2026.